Notoginsenoside R1
|
|
|
- CAS-Nr.
- 80418-24-2
- Englisch Name:
- Notoginsenoside R1
- Synonyma:
- NOTOGINSENOSIDE;Sanchinoside R1;NOTOGINSENOSIDE R1;Notoginsenoside Fb;Sanqi glucoside R1;Notoginseng extracts;Notoginsenoside R1-RM;NOTOGINSENOSIDE R1(SH);Notoginseng saponin R1;Notoginsenoside R1 ,98%
- CBNumber:
- CB0164186
- Summenformel:
- C47H80O18
- Molgewicht:
- 933.14
- MOL-Datei:
- 80418-24-2.mol
|
Notoginsenoside R1 Eigenschaften
- Schmelzpunkt:
- 215～217℃
- Siedepunkt:
- 1010.5±65.0 °C(Predicted)
- Dichte
- 1.39±0.1 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- L?slichkeit
- H2O: soluble1mg/mL, clear, colorless
- pka
- 12.85±0.70(Predicted)
- Aggregatzustand
- powder
- Farbe
- white to off-white
- Biologische Quelle
- Panax notoginseng (Burk.) F.H.Chen
- Wasserl?slichkeit
- H2O: 1mg/mL, clear, colorless
- Henry's Law Constant
- 6.6×1025 mol/(m3Pa) at 25℃, HSDB (2015)
- Major Application
- metabolomics
vitamins, nutraceuticals, and natural products
- InChIKey
- LLPWNQMSUYAGQI-OOSPGMBYSA-N
- LogP
- 1.354 (est)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung
|
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
|
P264, P270, P301+P312, P330, P501 |
| H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
|
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
|
P264, P280, P305+P351+P338,P337+P313P |
| H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
|
|
|
| Sicherheit |
| P261 |
Einatmen von Staub vermeiden. |
| P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
Notoginsenoside R1 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Notoginsenoside R1 acts as an anti-inflammatory agent, inhibiting TNF-α induced PAI-1 production in aortic smooth muscle cells in humans.
Notoginsenoside R1 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Notoginsenoside R1 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 375)Lieferanten
80418-24-2()Verwandte Suche:
- (3β,6α,12β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-β-D-xylopyranosyl-β-D-glucopyranoside
- Notoginsenoside Fb
- NOTOGINSENOSIDE R1
- NOTOGINSENOSIDE R1(SH)
- glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl2-O-β-D-xylopyranosyl-
- Sanchinoside R1
- Notoginsenoside R1，Sanchinoside R1
- Notoginsenoside R1 ,98%
- TIANFU-CHEM Notoginsenoside R1
- (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- (3beta,6alpha,12beta)-20-(beta-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-beta-D-Xylopyranosyl-beta-D-glucopyranoside
- β-D-Glucopyranoside, (3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-β-D-xylopyranosyl-
- Notoginsenoside R1 Standard
- Notoginseng extracts
- 2-[2-[6-[[4,5-dihydroxy-6-(hydroxymethyl)-3-methyl-2-oxanyl]oxy]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2
- Sanqi glucoside R1
- Notoginsenoside R1, 98%, from Panax notoginseng (Burk.)F.H.Chen
- Panax notoginseng saponin R1
- (2S,3R,4S,5S,6R)-2-(((S)-2-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-(((2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3,12-dihydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- Notoginseng saponin R1
- Notoginseng saponin FP2
- Panax Notoginseng Saponins, PNS
- Notoginsenoside R1-RM
- Notoginsenoside R1 Impurity
- Notoginsenoside R1, 10 mM in DMSO
- NOTOGINSENOSIDE
- Panax notoginsenoside R1
- 80418-24-2
- C47H80O18
- chemical reagent
- Inhibitors
- pharmaceutical intermediate
- phytochemical
- reference standards from Chinese medicinal herbs (TCM).
- standardized herbal extract
